OR WAIT null SECS
January 21, 2022
PharmaLex Group has merged with MAP Group, broadening its market access expertise and extending its reach into the Italian marketplace.
Cyxone has appointed a European CDMO to scale-up and produce the active ingredient of its T20K drug candidate.
Colorcon Ventures is investing in a provider of intelligent manufacturing execution systems (MES), Apprentice.io.
January 19, 2022
The company is voluntarily recalling one lot of Senna Syrup 8.8mg/5mL, unit-dose cups because of microbial contamination.
The agency discusses its response to COVID-19 and other milestones in its year-end review.
The agency’s COVID-19 task force says latest data shows use of COVID-19 mRNA vaccines during pregnancy is safe.
January 18, 2022
In their collaboration, Bristol Myers Squibb and Prellis Biologics aim to generate human antibody libraries for select targets to enable drug discovery.
After a previously announced merger, Protagen Protein Services, BioAnalytix, and GeneWerk have formed a new CRO under the name ProtaGene.
January 17, 2022
Pfizer will pay Beam $300 million upfront to conduct research on three undisclosed base editing targets in the liver, muscle, and central nervous system.
CDMO Forge Biologics will accelerate its manufacturing capacity expansion using an additional $80 million in funding it recently secured.